Underuse of beta-blockers following myocardial infarction: A tale of two cities

Stephen Nicholls, P. McElduff, A. J. Dobson, K. D. Jamrozik, M. S.T. Hobbs, James W. Leitch

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aims: To measure factors associated with underuse of beta-blocker therapy after myocardial infarction (MI). Methods: The Newcastle and Perth collaborating centres of the World Health Organization (WHO) MONICA project (to MONItor trends and determinants of Cardiovascular disease) systematically evaluated all patients admitted to hospital in their respective regions with possible MI. A total of 1766 patients in Newcastle and 4503 patients in Perth, discharged from hospital after confirmed MI from 1985 to 1993, were studied. Rates of beta-blocker use before and after hospital discharge were evaluated and correlates of beta-blocker use determined. Results: Beta-blocker use was similar in Newcastle and Perth before MI (21% of patients in each centre). During hospital admission, beta-blocker therapy was initiated nearly twice as frequently in Perth compared with Newcastle (66 vs 36%, respectively) and more patients were discharged from hospital on beta-blockers in Perth (68%) than in Newcastle (45%). The main factors associated with underuse of beta-blockers in multivariate analysis were geographical centre (odds ratio (OR) for Newcastle compared with Perth 0.3; 95% confidence interval (CI) 0.3-0.3), a history of previous MI (OR 0.6, 95% CI 0.5-0.7), admission to hospital in earlier years (OR 0.4, 95% CI 0.3-0.4 for years 1985-87 compared with years 1991-93), diabetes (OR 0.6, 95% CI 0.5-0.8) and the concomitant use of diuretics (OR 0.5, 95% CI 0.4-0.6) and calcium antagonists (OR 0.6, 95% CI 0.5-0.8). Conclusions: Underuse of beta-blockers after MI was strongly related to hospital prescribing patterns and not to community use of beta-blockers. Underuse occurred in patients with diabetes and in patients with left ventricular dysfunction, patients who stand to benefit most from beta-blocker use following MI.

LanguageEnglish
Pages391-396
Number of pages6
JournalInternal Medicine Journal
Volume31
Issue number7
DOIs
Publication statusPublished - 1 Jan 2001

Keywords

  • Beta-blocker
  • Hospital size
  • Myocardial infarction
  • Newcastle
  • Perth

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Nicholls, S., McElduff, P., Dobson, A. J., Jamrozik, K. D., Hobbs, M. S. T., & Leitch, J. W. (2001). Underuse of beta-blockers following myocardial infarction: A tale of two cities. Internal Medicine Journal, 31(7), 391-396. https://doi.org/10.1046/j.1445-5994.2001.00098.x
Nicholls, Stephen ; McElduff, P. ; Dobson, A. J. ; Jamrozik, K. D. ; Hobbs, M. S.T. ; Leitch, James W. / Underuse of beta-blockers following myocardial infarction : A tale of two cities. In: Internal Medicine Journal. 2001 ; Vol. 31, No. 7. pp. 391-396.
@article{0b546f830b9c4377a9179606549e555f,
title = "Underuse of beta-blockers following myocardial infarction: A tale of two cities",
abstract = "Aims: To measure factors associated with underuse of beta-blocker therapy after myocardial infarction (MI). Methods: The Newcastle and Perth collaborating centres of the World Health Organization (WHO) MONICA project (to MONItor trends and determinants of Cardiovascular disease) systematically evaluated all patients admitted to hospital in their respective regions with possible MI. A total of 1766 patients in Newcastle and 4503 patients in Perth, discharged from hospital after confirmed MI from 1985 to 1993, were studied. Rates of beta-blocker use before and after hospital discharge were evaluated and correlates of beta-blocker use determined. Results: Beta-blocker use was similar in Newcastle and Perth before MI (21{\%} of patients in each centre). During hospital admission, beta-blocker therapy was initiated nearly twice as frequently in Perth compared with Newcastle (66 vs 36{\%}, respectively) and more patients were discharged from hospital on beta-blockers in Perth (68{\%}) than in Newcastle (45{\%}). The main factors associated with underuse of beta-blockers in multivariate analysis were geographical centre (odds ratio (OR) for Newcastle compared with Perth 0.3; 95{\%} confidence interval (CI) 0.3-0.3), a history of previous MI (OR 0.6, 95{\%} CI 0.5-0.7), admission to hospital in earlier years (OR 0.4, 95{\%} CI 0.3-0.4 for years 1985-87 compared with years 1991-93), diabetes (OR 0.6, 95{\%} CI 0.5-0.8) and the concomitant use of diuretics (OR 0.5, 95{\%} CI 0.4-0.6) and calcium antagonists (OR 0.6, 95{\%} CI 0.5-0.8). Conclusions: Underuse of beta-blockers after MI was strongly related to hospital prescribing patterns and not to community use of beta-blockers. Underuse occurred in patients with diabetes and in patients with left ventricular dysfunction, patients who stand to benefit most from beta-blocker use following MI.",
keywords = "Beta-blocker, Hospital size, Myocardial infarction, Newcastle, Perth",
author = "Stephen Nicholls and P. McElduff and Dobson, {A. J.} and Jamrozik, {K. D.} and Hobbs, {M. S.T.} and Leitch, {James W.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1046/j.1445-5994.2001.00098.x",
language = "English",
volume = "31",
pages = "391--396",
journal = "Australian and New Zealand Journal of Medicine",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "7",

}

Nicholls, S, McElduff, P, Dobson, AJ, Jamrozik, KD, Hobbs, MST & Leitch, JW 2001, 'Underuse of beta-blockers following myocardial infarction: A tale of two cities', Internal Medicine Journal, vol. 31, no. 7, pp. 391-396. https://doi.org/10.1046/j.1445-5994.2001.00098.x

Underuse of beta-blockers following myocardial infarction : A tale of two cities. / Nicholls, Stephen; McElduff, P.; Dobson, A. J.; Jamrozik, K. D.; Hobbs, M. S.T.; Leitch, James W.

In: Internal Medicine Journal, Vol. 31, No. 7, 01.01.2001, p. 391-396.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Underuse of beta-blockers following myocardial infarction

T2 - Australian and New Zealand Journal of Medicine

AU - Nicholls, Stephen

AU - McElduff, P.

AU - Dobson, A. J.

AU - Jamrozik, K. D.

AU - Hobbs, M. S.T.

AU - Leitch, James W.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Aims: To measure factors associated with underuse of beta-blocker therapy after myocardial infarction (MI). Methods: The Newcastle and Perth collaborating centres of the World Health Organization (WHO) MONICA project (to MONItor trends and determinants of Cardiovascular disease) systematically evaluated all patients admitted to hospital in their respective regions with possible MI. A total of 1766 patients in Newcastle and 4503 patients in Perth, discharged from hospital after confirmed MI from 1985 to 1993, were studied. Rates of beta-blocker use before and after hospital discharge were evaluated and correlates of beta-blocker use determined. Results: Beta-blocker use was similar in Newcastle and Perth before MI (21% of patients in each centre). During hospital admission, beta-blocker therapy was initiated nearly twice as frequently in Perth compared with Newcastle (66 vs 36%, respectively) and more patients were discharged from hospital on beta-blockers in Perth (68%) than in Newcastle (45%). The main factors associated with underuse of beta-blockers in multivariate analysis were geographical centre (odds ratio (OR) for Newcastle compared with Perth 0.3; 95% confidence interval (CI) 0.3-0.3), a history of previous MI (OR 0.6, 95% CI 0.5-0.7), admission to hospital in earlier years (OR 0.4, 95% CI 0.3-0.4 for years 1985-87 compared with years 1991-93), diabetes (OR 0.6, 95% CI 0.5-0.8) and the concomitant use of diuretics (OR 0.5, 95% CI 0.4-0.6) and calcium antagonists (OR 0.6, 95% CI 0.5-0.8). Conclusions: Underuse of beta-blockers after MI was strongly related to hospital prescribing patterns and not to community use of beta-blockers. Underuse occurred in patients with diabetes and in patients with left ventricular dysfunction, patients who stand to benefit most from beta-blocker use following MI.

AB - Aims: To measure factors associated with underuse of beta-blocker therapy after myocardial infarction (MI). Methods: The Newcastle and Perth collaborating centres of the World Health Organization (WHO) MONICA project (to MONItor trends and determinants of Cardiovascular disease) systematically evaluated all patients admitted to hospital in their respective regions with possible MI. A total of 1766 patients in Newcastle and 4503 patients in Perth, discharged from hospital after confirmed MI from 1985 to 1993, were studied. Rates of beta-blocker use before and after hospital discharge were evaluated and correlates of beta-blocker use determined. Results: Beta-blocker use was similar in Newcastle and Perth before MI (21% of patients in each centre). During hospital admission, beta-blocker therapy was initiated nearly twice as frequently in Perth compared with Newcastle (66 vs 36%, respectively) and more patients were discharged from hospital on beta-blockers in Perth (68%) than in Newcastle (45%). The main factors associated with underuse of beta-blockers in multivariate analysis were geographical centre (odds ratio (OR) for Newcastle compared with Perth 0.3; 95% confidence interval (CI) 0.3-0.3), a history of previous MI (OR 0.6, 95% CI 0.5-0.7), admission to hospital in earlier years (OR 0.4, 95% CI 0.3-0.4 for years 1985-87 compared with years 1991-93), diabetes (OR 0.6, 95% CI 0.5-0.8) and the concomitant use of diuretics (OR 0.5, 95% CI 0.4-0.6) and calcium antagonists (OR 0.6, 95% CI 0.5-0.8). Conclusions: Underuse of beta-blockers after MI was strongly related to hospital prescribing patterns and not to community use of beta-blockers. Underuse occurred in patients with diabetes and in patients with left ventricular dysfunction, patients who stand to benefit most from beta-blocker use following MI.

KW - Beta-blocker

KW - Hospital size

KW - Myocardial infarction

KW - Newcastle

KW - Perth

UR - http://www.scopus.com/inward/record.url?scp=0035758267&partnerID=8YFLogxK

U2 - 10.1046/j.1445-5994.2001.00098.x

DO - 10.1046/j.1445-5994.2001.00098.x

M3 - Article

VL - 31

SP - 391

EP - 396

JO - Australian and New Zealand Journal of Medicine

JF - Australian and New Zealand Journal of Medicine

SN - 1444-0903

IS - 7

ER -